NANCY DENYES

Insider Reports History

Location
San Diego, CA
Signature
/s/ Nancy E. Denyes
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by NANCY DENYES:

Company Role Class Num Shares Value Price $ Report Date Ownership
aTYR PHARMA INC General Counsel Common Stock 26,555 $100,378 $3.78 04 Feb 2025 Direct
aTYR PHARMA INC General Counsel Restricted Stock Unit 2,687 $10,157 $3.78 03 Feb 2025 Direct
aTYR PHARMA INC General Counsel Restricted Stock Unit 5,374 $6,331 $1.18 05 Feb 2024 Direct
aTYR PHARMA INC General Counsel Employee Stock Option (right to buy) 275,000 08 Jan 2025 Direct

Insider Reports Filed by NANCY DENYES

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ATYR aTYR PHARMA INC 03 Feb 2025 3 -$3,398 4 General Counsel 04 Feb 2025, 18:11
ATYR aTYR PHARMA INC 08 Jan 2025 1 $0 4 General Counsel 10 Jan 2025, 16:01
ATYR aTYR PHARMA INC 05 Jun 2024 1 $9,276 4 General Counsel 06 Jun 2024, 08:26
LIFE aTYR PHARMA INC 05 Feb 2024 2 $0 4 General Counsel 06 Feb 2024, 20:15
LIFE aTYR PHARMA INC 05 Jan 2024 1 $0 4 General Counsel 09 Jan 2024, 19:30
LIFE aTYR PHARMA INC 16 Feb 2023 1 $0 4 General Counsel 21 Feb 2023, 16:00
LIFE aTYR PHARMA INC 03 Feb 2023 2 $0 4 General Counsel 06 Feb 2023, 18:03
LIFE aTYR PHARMA INC 24 May 2022 1 $0 4 General Counsel 26 May 2022, 16:34
LIFE aTYR PHARMA INC 03 Feb 2022 2 $0 4 General Counsel 07 Feb 2022, 15:59
LIFE aTYR PHARMA INC 21 May 2021 1 $0 4 General Counsel 25 May 2021, 21:06